Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
CLARITIN (LORATIDINE) COULD ADD $200-$300 MIL. IN SALES TO SCHERING's WORLDWIDE DRUG BUSINESS ONCE ESTABLISHED, PRESIDENT KOGAN TELLS ANALYSTS: LAUNCH IN EARLY 1988
Dec 07 1987
•
By
The Pink Sheet
More from Archive
More from Pink Sheet